Leukotriene receptor antagonists: clinical effects.
作者信息
Barnes N
机构信息
Department of Respiratory Medicine, London Chest Hospital, England.
出版信息
J R Soc Med. 1997 Apr;90(4):200-4. doi: 10.1177/014107689709000405.
Abstract
摘要
相似文献
1
Leukotriene receptor antagonists: clinical effects.白三烯受体拮抗剂：临床疗效。
J R Soc Med. 1997 Apr;90(4):200-4. doi: 10.1177/014107689709000405.
2
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.白三烯、白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的应用进展。第一部分：白三烯的合成、受体及其在哮喘中的作用
Pharmacol Res. 1999 Jul;40(1):3-13. doi: 10.1006/phrs.1998.0458.
3
Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.白三烯、白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的应用：最新进展。第二部分：白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的临床研究
Pharmacol Res. 1999 Jul;40(1):15-29. doi: 10.1006/phrs.1998.0461.
4
Leukotrienes, antileukotrienes and asthma.白三烯、抗白三烯与哮喘
Mini Rev Med Chem. 2008 Jun;8(7):647-56. doi: 10.2174/138955708784567395.
5
[Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].[支气管哮喘的新疗法：白三烯受体拮抗剂和白三烯合成抑制剂的应用]
Ned Tijdschr Geneeskd. 1998 Jan 10;142(5):72-8.
6
Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.半胱氨酰白三烯的病理生理学及白三烯受体拮抗剂在哮喘中的作用
Allergy. 2001;56 Suppl 66:7-11. doi: 10.1034/j.1398-9995.56.s66.2.x.
7
Anti-leukotrienes for asthma.用于治疗哮喘的抗白三烯药物。
Curr Opin Pharmacol. 2001 Jun;1(3):230-4. doi: 10.1016/s1471-4892(01)00041-8.
8
Treatment of asthma with drugs modifying the leukotriene pathway.使用改变白三烯途径的药物治疗哮喘。
N Engl J Med. 1999 Jan 21;340(3):197-206. doi: 10.1056/NEJM199901213400306.
9
[Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors].[白三烯与哮喘。白三烯受体拮抗剂和白三烯合成抑制剂的临床及实验经验]
Tidsskr Nor Laegeforen. 1997 Feb 20;117(5):647-51.
10
Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.哮喘与白三烯：抗白三烯药物作为新型抗哮喘药物
J Intern Med. 1999 Mar;245(3):205-27. doi: 10.1046/j.1365-2796.1999.00418.x.
引用本文的文献
1
Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).普仑司特可预防半趾蟾（Cryptotis parva）中半胱氨酰白三烯诱导的呕吐。
Eur J Pharmacol. 2010 Feb 25;628(1-3):195-201. doi: 10.1016/j.ejphar.2009.11.030. Epub 2009 Nov 24.
本文引用的文献
1
Liberation of histamine and formation of lysocithin-like substances by cobra venom.眼镜蛇毒导致组胺释放及溶血卵磷脂样物质的形成。
J Physiol. 1938 Nov 14;94(2):187-226. doi: 10.1113/jphysiol.1938.sp003674.
2
The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.过敏性休克期间组胺的释放及慢反应物质（SRS-A）的形成。
J Physiol. 1960 Jun;151(3):416-35. doi: 10.1113/jphysiol.1960.sp006449.
3
Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.白三烯拮抗剂ONO - 1078对哮喘患者支气管高反应性的影响。
Respir Med. 1993 Feb;87(2):133-8. doi: 10.1016/0954-6111(93)90141-l.
4
5
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses.口服白三烯抑制剂（MK-886）可阻断变应原诱导的气道反应。
Am Rev Respir Dis. 1993 Apr;147(4):839-44. doi: 10.1164/ajrccm/147.4.839.
6
Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.白三烯受体拮抗剂MK-0679对阿司匹林敏感哮喘患者基线肺功能的影响。
Thorax. 1993 Dec;48(12):1205-10. doi: 10.1136/thx.48.12.1205.
7
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma.齐留通抑制5-脂氧合酶对轻至中度哮喘的影响。
Ann Intern Med. 1993 Dec 1;119(11):1059-66. doi: 10.7326/0003-4819-119-11-199312010-00001.
8
Leukotriene E4 and granulocytic infiltration into asthmatic airways.白三烯E4与粒细胞浸润至哮喘气道
Lancet. 1993 Apr 17;341(8851):989-90. doi: 10.1016/0140-6736(93)91073-u.
9
Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.口服白三烯D4受体拮抗剂ICI 204,219对支气管哮喘患者进行6周治疗的效果。ACCOLATE哮喘试验组。
Am J Respir Crit Care Med. 1994 Sep;150(3):618-23. doi: 10.1164/ajrccm.150.3.8087328.
10
Inversely-correlated inhibition of human 5-lipoxygenase activity by BAY X1005 and other quinoline derivatives in intact cells and a cell-free system--implications for the function of 5-lipoxygenase activating protein.BAY X1005及其他喹啉衍生物在完整细胞和无细胞体系中对人5-脂氧合酶活性的负相关抑制作用——对5-脂氧合酶激活蛋白功能的启示
Biochem Pharmacol. 1994 Jun 15;47(12):2259-68. doi: 10.1016/0006-2952(94)90264-x.
Zotero 插件